These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8103890)
1. Stibogluconate for leishmaniasis. Misbahuddin M; Jahan K; Chowdhury MA; Absar N Lancet; 1993 Sep; 342(8874):804. PubMed ID: 8103890 [No Abstract] [Full Text] [Related]
2. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium]. Fuzaĭlov IuM Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277 [No Abstract] [Full Text] [Related]
3. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report. Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588 [No Abstract] [Full Text] [Related]
4. Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate. Collins M; Carter KC; Baillie AJ Ann Trop Med Parasitol; 1992 Feb; 86(1):35-40. PubMed ID: 1319700 [TBL] [Abstract][Full Text] [Related]
5. Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis. Roberts WL; Hariprashad J; Rainey PM; Murray HW Am J Trop Med Hyg; 1996 Oct; 55(4):444-6. PubMed ID: 8916804 [TBL] [Abstract][Full Text] [Related]
11. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India. Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981 [TBL] [Abstract][Full Text] [Related]
12. Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature. Collini P; Premchand N; Lockwood D; Greig J Ann Trop Med Parasitol; 2009 Jul; 103(5):455-9. PubMed ID: 19583915 [No Abstract] [Full Text] [Related]
13. [Treatment of visceral leishmaniasis in children]. Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279 [TBL] [Abstract][Full Text] [Related]
14. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Chunge CN; Owate J; Pamba HO; Donno L Trans R Soc Trop Med Hyg; 1990; 84(2):221-5. PubMed ID: 2167522 [TBL] [Abstract][Full Text] [Related]
15. Recurrent episodes of thrombocytopenia during treatment with sodium stibogluconate. Braconier JH; Miörner H J Antimicrob Chemother; 1993 Jan; 31(1):187-8. PubMed ID: 8383103 [No Abstract] [Full Text] [Related]
16. Hepatotoxicity of sodium stibogluconate in leishmaniasis. Hepburn NC; Siddique I; Howie AF; Beckett GJ; Hayes PC Lancet; 1993 Jul; 342(8865):238-9. PubMed ID: 8100955 [No Abstract] [Full Text] [Related]
17. Jejunal function and pathology in visceral Leishmaniasis. Muigai R; Gatei DG; Shaunak S; Wozniak A; Bryceson AD Lancet; 1983 Aug; 2(8348):476-9. PubMed ID: 6136644 [TBL] [Abstract][Full Text] [Related]
18. Experience with amphotericin B in sodium stibogluconate--unresponsive cases of visceral Leishmaniasis in north Bihar. Giri OP; Singh AN J Assoc Physicians India; 1994 Sep; 42(9):690-1. PubMed ID: 7883660 [TBL] [Abstract][Full Text] [Related]
19. A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Chulay JD; Bhatt SM; Muigai R; Ho M; Gachihi G; Were JB; Chunge C; Bryceson AD J Infect Dis; 1983 Jul; 148(1):148-55. PubMed ID: 6309993 [TBL] [Abstract][Full Text] [Related]